At SupplySide Global 2026, Jordi Riera of Kaneka Probiotics describes the company’s focus on research and probiotics for women’s health.
|Articles|April 19, 2011
Study Examines Effects of Cranberries on Women’s UTI
The 90-day, randomized, double-blind, controlled study administered a daily dose of 500 mg of PACran.
Advertisement
Decas Botanical Synergies (Carver, MA) announced the publication of a
The 90-day, randomized, double-blind, controlled study administered a daily dose of 500 mg of PACran. The company says that at the end of the treatment period, results showed a significant reduction in the presence of E. coli and support for urinary tract health.
Advertisement
Related to this article
Ixoreal Biomed highlights an exploratory placebo-controlled study of SRI-81 Shatavari, alone and combined with KSM-66 Ashwagandha, published in the International Journal of Women’s Health.
A randomized, double-blind, placebo-controlled trial in reproductive-age women found that 8 weeks of standardized shatavari extract supplementation was associated with improvements in sexual function, vaginal moisture, fatigue, and sleep disturbance.
Why responsible innovation means asking whether yesterday's formulations still reflect today's best science—not just launching the next new ingredient.
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
What the Interim Compounding Pathway for Peptides Could Mean for Supplement Brands
2
Formulating With Functional Mushrooms: What Extraction and Dose Mean for Beverages and Foods
3
Vitaquest's 2027 Consumer Trends Forecast
4
SupplySide Global Panel Weighs Purpose, Transparency, and Affordability in Nutrition
5